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The critical importance of cytoskeletal function for correct neuronal migration during development of the cerebral cortex has been
underscored by the identities of germline mutations underlying a number of human neurodevelopmental disorders. The proteins
affected include TUBA1A, amajor a-tubulin isoform, andmicrotubule-associated components such as doublecortin, and LIS1.Mutations
in these genes are associated with the anatomical abnormality lissencephaly, which is believed to reﬂect failure of neuronal migration.
An important recent observation has been the dependence of cortical neuronal migration upon acetylation of a-tubulin at lysine 40 by
the histone acetyltransferase Elongator complex. Here, we describe a recognizable autosomal recessive syndrome, characterized by
generalized polymicrogyria in association with optic nerve hypoplasia (PMGOH). By autozygosity mapping, we show that themolecular
basis for this condition is mutation of the TUBA8 gene, encoding a variant a-tubulin of unknown function that is not susceptible to the
lysine 40 acetylation that regulatesmicrotubule function during cortical neuronmigration. Together with the unique expression pattern
of TUBA8within the developing cerebral cortex, these observations suggest a role for this atypical microtubule component in regulating
mammalian brain development.Polymicrogyria (PMG) is a malformation of the cerebral
cortex in which the usual gyral pattern is replaced by
numerous small infoldings, separated by sulci, which
fuse inferiorly, and the normally six-layered cortex is
replaced by a four-layered or unlayered cortex.1 PMG can
be a focal lesion or a more generalized cortical abnormality
and may be accompanied by other malformations,
including agenesis of the corpus callosum, microcephaly,
or cerebellar vermis hypoplasia. Localized PMG is most
commonly perisylvian, but has been described in all areas
of the brain, with its extent and location determining the
neurological manifestations. Within a developmental clas-
siﬁcation of brain malformations, the PMG spectrum is
believed to reﬂect abnormal late neuronal migration and
cortical organization, unlike the lissencephalies, which
are characterized by defective migration earlier in cortical
development.1
Bilateral PMG has been recognized in various genetic
disorders; mutations in RAB3GAP1 (MIM 602536),2 SRPX2
(MIM 300642),3 PAX6 (MIM 607108),4 TBR2 (MIM
604615),5 COL18A1 (MIM 120328),6 and KIAA1279
(MIM 609367)7 have been associated with PMG. However,
these all appear to represent syndromes in which PMG is
only an occasional feature. In contrast, it has been difﬁcult
to delineate clinical disorders in which PMG is a hallmark
lesion, and genetic clues to the pathogenesis of PMG haveThe Americanconsequently been lacking. One exception is the syn-
drome of bilateral frontoparietal polymicrogyria (BFPP
[MIM 606854]), caused by mutations that interfere with
the N-glycosylation of the GPR56 protein (GPR56 [MIM
604110]).8 Notably, though, the radiological appearance
of BFPP resembles those of the so-called cobblestone mal-
formations, the result of O-glycosylation defects in the
developing brain.9 BFPP is in this respect rather distinct
from other PMGs, which are thought to be the result of
abnormal cortical organization.1
We assessed four children from two consanguineous
families of Pakistani origin, all of whom presented with
similar clinical features; the two families were not know-
ingly related to each other (Figure 1). Written informed
consent for the studies was obtained from subjects or their
parents, in accordance with a protocol approved by the
Leeds (East) Research Ethics Committee (reference 07/
H1306/113).
The children had a constellation of severe develop-
mental delay, hypotonia, and seizures. One child died at
age 2 from an overwhelming respiratory infection, whereas
the others have survived with profound neurological
impairment. None of the children was dysmorphic; how-
ever, optic nerve hypoplasia was observed on ophthalmos-
copy in all four subjects. Clinical details are found in
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Figure 1. Pedigrees of Two Families with PMG and Optic Hypoplasia
In each case, the proband is indicated by an arrow.Neuroimaging revealed a pattern of extensive PMG, with
a dysplastic or absent corpus callosum and hypoplastic
optic nerves. In addition, there was a distinctive abnor-
mality of the brainstem, in which the normal sharp demar-
cation between the pons and medulla was absent, with the
pontine bulge extending too far caudally (Figure 2 and
Figures S1–S6 available online).
The structure of family 1 and the consanguinity in both
families suggested an autosomal-recessive disorder. We
therefore performedaSNP-microarray genome-widehomo-
zygosity scan by using the Affymetrix Genome-Wide
Human SNP Array 6.0. SNP genotypes were analyzed
with AutoSNPa10 and IBDﬁnder software11 for identifying
regionsof concordanthomozygosity in affected individuals
from both families. Mutation analysis was performed by
direct sequencing of puriﬁed genomic PCR products, using
an Applied Biosystems 3130xl Genetic Analyzer (primer
sequences and experimental conditions listed in Table S1.
Anonymized control sampleswere screenedbygenoytping.
SNP genotyping revealed no call rates averaging 8.5%.
Markers not called in all four cases were eliminated. A
single 7.42 Mb region of concordant homozygosity on
chromosome 22q11.2 in affected individuals, bounded
by SNP markers rs4607032 (16.22 Mb) and rs139764
(23.64Mb), was identiﬁed. There were 929 SNPs within
the shared minimal autozygous region. IBDﬁnder and
AutoSNPa analysis revealed no other regions of shared738 The American Journal of Human Genetics 85, 737–744, Novemconcordant homozygosity between the four cases. The
centromeric boundary of the shared region was deﬁned
by heterozygosity for rs4607032 in case 4 (individual
IV:1 in family 2) and the telomeric boundary by heterozy-
gous SNP rs139764 in case 1. Within this region, we also
conﬁrmed concordant homozygosity for microsatellite
markers D22S420 (16.24 Mb), D22S427 (16.97 Mb),
D22S264 (19.10 Mb), D22S446 (20.35 Mb), and D22S539
(20.59 Mb). The combined genotyping data are therefore
strongly indicative of a common ancestral background
for this autozygous region in both families.
The minimal autozygous interval contains more than
230 annotated genes (after exclusion of the immunoglob-
ulin l cluster). Of immediate note, however, was the a8-
tubulin gene (TUBA8 [MIM 605742]).12 Dominant muta-
tions in the a1-tubulin gene (TUBA1A [MIM 602529]) are
known to cause lissencephaly associated with mild micro-
cephaly and dysgenesis of the corpus callosum and brain-
stem hypoplasia.13–15 More recently, dominant mutations
in TUBB2B (MIM 812650) resulting in an asymmetric
frontal predominant PMG with corpus callosum dysgen-
esis have also been described.16 TUBA8 (known to be
expressed in the brain12) was therefore an obvious candi-
date gene. Sequencing in the affected members of the
two families revealed no coding region variants, but
a homozygous 14 bp deletion in intron 1 of TUBA8 was
identiﬁed (Figure 3A). This segregated with the disease inber 13, 2009
Table 1. Clinical Features in Affected Individuals
Patient Information
Patient 1 2 3 4
Family ID Family 1 Family 1 Family 1 Family 2
Pedigree position VII:1 VII:5 VI:5 IV:1
Age at last review 30 months 4.5 years 12 years 2.5 years
Clinical Feature
Gestation Term Term Term Term
Delivery Normal vaginal Normal vaginal Normal vaginal Normal vaginal
Birthweight 2975 g 3200 g N/A 2675 g
Occipitofrontal
circumference
3 centile 0.4 centile 25centile 25 centile
Neonatal hypotonia þ N/A þ þ
Obtunded reﬂexes þ þ þ þ
Seizure onset 2 months 5 days 4 months Six months
Seizure type Infantile spasms Tonic clonic Tonic clonic Tonic clonic
Speech None None None None
Motor development Unable to sit Unable to sit Unable to sit Unable to sit
Ophthalmoscopy Optic nerve hypoplasia Optic nerve hypoplasia Optic nerve hypoplasia Optic nerve hypoplasia
Neuroimaging





Extensive bilateral PMG Extensive bilateral PMG,
both anterior and
posterior




with loss of demarcation
of pontomedullary
junction
Loss of demarcation of the
pontomedullary junction
Loss of demarcation of the
pontomedullary junction
Loss of demarcation of the
pontomedullary junction
Other features Colpocephaly Colpocephaly Colpocephaly
þ, feature present; N/A, information not available.both families, and all obligate carriers were heterozygous
for the mutation. The mutation was not present in 342
ethnically matched control chromosomes.
The deletion lies 11 bp upstream of the exon 2 splice
junction, eliminating a large portion of the acceptor site
polypyrimidine tract. In silico analysis accordingly pre-
dicted that it would interfere with correct splicing of
exon 2. To conﬁrm this, we analyzed lymphoblastoid cell
line (LCL) RNA from case 1 by using RT-PCR (Figure 3B).
Total RNA from EBV-transformed lymphoblastoid cells
was extracted with Trizol (Invitrogen, Renfrew, UK).
Reverse transcription and PCR were performed with the
Thermoscript RT-PCR system (Invitrogen Life Technolo-
gies), in accordance with the manufacturer’s instructions.
(Primer sequences and experimental conditions are listed
in Table S1.)
The full-length TUBA8 transcript was found at greatly
reduced level, the major species being a shortened tran-
script, conﬁrmed by sequencing to lack exon 2. SimilarlyThe Americanshortened RT-PCR products were obtained using various
primer pairs ﬂanking exon 2, in each case a low level of
full-length transcript being detectable (Figure 3B). RT-PCR
with one primer in exon 2 conﬁrmed that a low level of
correctly spliced exon 2-containing mRNA was detectable
in the patient LCL. In his heterozygous father, RT-PCR
product from the full-length transcript predominates
over the shortenedmutant product (even though the latter
is expected to amplify more efﬁciently), implying greatly
reduced level of the aberrantly spliced RNA, most likely
because it is unstable.
We next investigated the expression pattern of Tuba8 in
the developing mouse brain by using RNA in situ hybrid-
ization. In brief, digoxigenin-labeled Tuba8 riboprobes
were generated by antisense (SP6) and sense (control, T7)
in vitro transcription of a 443-bp region comprising
the 30 end of mouse Tuba8 cDNA (nt 990–1432 of
NM_017379 inclusive), cloned into pGEM-T Easy (Prom-
ega UK, Southampton). Mouse embryos were collectedJournal of Human Genetics 85, 737–744, November 13, 2009 739
under an approved animal research protocol. Tissue prepa-
ration and nonradioactive RNA in situ hybridization and
visualization were performed as previously described.17
Tuba8 was found to be widely expressed in developing
neural structures. At embryonic day (E) 13.5, Tuba8 is
expressed in the cortical preplate (PP) and cingulate cortex
(CiC).There is also evidence of weaker expression in the
subventricular zone (SVZ)/mantle zone of the ganglionic
eminence (GE) (Figures 4A and 4F); these cells will be
undergoing ﬁnal divisions and then making tangential
migrations through the mantle zone to the cortex. By
E15.5 (Figures 4B and 4G), the strongest expression is
seen in the cortical plate (CP); there is fainter labeling in
the SVZ and intermediate zone (IZ). There is now addi-
tional expression visible in the hypothalamus (Figure 4K).
By E18.5, cortical expression is most intense in the upper
layers and subplate (SP) (Figures 4C and 4H). There is
strong expression in the areas CA1-3 of the hippocampus
Figure 2. Magnetic Resonance Images of Affected Individual
IV:1 from Family 2
(A) The corpus callosum is absent, as is the cingulate gyrus (hollow
white arrow). Disorganized gyral folds radiate toward a high-riding
third ventricle. A prominent massa intermedia is seen (black
arrow). There is malformation of the brainstem, with loss of
demarcation of the pontomedullary junction (solid white arrow).
(B) The cortex is thickened and the gyral pattern is abnormal.
There is generalized PMG (black arrows), and agenesis of the
corpus callosum has resulted in colpocephaly (white arrows).
(C) Coronal section at the level of the third ventricle, demon-
strating absence of the corpus callosum with a ‘‘Viking helmet’’
conﬁguration of the frontal horns and a high-riding third
ventricle.740 The American Journal of Human Genetics 85, 737–744, Novem(Figure 4L). At P0, cortical expression is strongest in the
dense cortical plate and subplate (Figures 4D and 4I).
Hippocampal expression is more intense in areas CA1-3
than in the dentate gyrus (Figure 4M). At P8 (Figures 4E
and 4J), lamination is almost complete and cortical expres-
sion is strongest in layers II–III and V and the subplate.
There is also expression in the mediodorsal nuclei of the
thalamus, the mitral cell layer of the olfactory bulb, and
the external granular layer, molecular layer, and internal
granular cell layer of the cerebellum (Figure 4O).
Very recently, de novo dominant mutations in a b-tubu-
lin gene, TUBB2B, have been described in children who
have an asymmetrical PMG, together with corpus callosum
dysgenesis, abnormal basal ganglia, cerebellar dysplasia,
and brainstem hypoplasia.16 There are similarities between
the Tuba8 expression pattern we have observed with that
reported for Tubb2b16 in the developing brain, but these
are not maintained postnatally. At E15.5–E16.5, both
Tuba8 and Tubb2b are expressed in the cortical plate and
subplate, with little expression in the marginal zone and
weaker expression in the ventricular and intermediate
zones. In contrast, expression of the lissencephaly-associ-
ated Tuba1a protein is strong in the migratory cells of
the intermediate zone at similar time points.14 Taken
together, these data suggest that Tuba8, like Tubb2b, is
strongly expressed in postmitotic cortical neurons.18–20
However, by P8, the strongest expression of Tuba8 is in
cortical layers II–III and V and the subplate, whereas
expression of Tubb2b decreases in the postnatal cortex.16
These data suggest that Tuba8 has a role in neuronal migra-
tion of deep-layer neurons but that its expression is further
upregulated once the cells reach the cortical plate. This
Figure 3. Splicing Mutation of TUBA8 in PMGOH-Affected Indi-
viduals
(A) Schematic to show site and extent of 14-bp deletion mutation.
(B) Reverse transcription PCR analysis of LCL RNA. The skipped
exon 2 is shaded light gray, coding regions of other exons are
shown in dark gray. The following abbreviations are used: N,
normal control; H, heterozygote; and P, patient (homozygous).ber 13, 2009
Figure 4. Tuba8 Expression Studied with In Situ Hybridization during Mouse Brain Development
(A–D) Coronal sections at E13.5, E15.5, E18, and P0.
(E) Sagittal section at P8. In (A)–(E), dashed boxes refer to areas shown enlarged in (F)–(J).
(K–N) Hippocampus at E15, E18, P0, and P8.
(O) Cerebellum at P8.
(A and F) At E13.5 there is generally stronger expression in the postmitotic layers of the telencephalon, such as dorsal cortex and cingu-
late cortex (CiC), ganglionic eminence (GE). There is also evidence of expression inmigratory cells of the SVZ/mantle zone of the gangli-
onic eminence (GE).
(B and G) By E15.5 (B) the strongest expression is in the emerging cortical plate of the dorsal cortex, in perirhinal cortex (PRh), CiC and
GE. High magniﬁcation (G) reveals most intense expression in cortical plate (CP), but there is also expression in the subventricular zone
(SVZ), and intermediate zone (IZ).
(C and H) At E18.5 (C) the cortical expression becomes more intense in the upper layers and subplate, with relatively less expression in
putative layer VI. The VZ has stronger expression at this age (H) than at E15.5 (G). The dorsal and perirhinal cortices have stronger
expression than piriform cortex (Pir).
(D and I) At P0 the strongest cortical expression is in the layer of still migrating cortical neurons of the dense cortical plate (DCP) and
subplate (SP). There is continued expression in the perirhinal cortex (PRh). The mediodorsal nuclei (md) of the thalamus (Th) have
strong Tuba8 expression.
(E and J) By P8, the cortical lamination is close to completion. The strongest expression of Tuba8 is in layers II–III and Vand the subplate.
The expression in the dorsomedial thalamus has been maintained, and in the olfactory bulb (OB) expression can be seen in the mitral
cell layer (MiL).
(K) The pyramidal layer of the hippocampus also starts to express Tuba8 from E15.
(L) At E 18 there is strong expression of Tuba8 in the CA1-3 region of the hippocampus, with lower expression in dentate gyrus (DG).
(M) At P0 there is strong Tuba8 expression in the hippocampus, more intense in regions CA1-3 than the dentate gyrus.
(N) At P8 in the hippocampus there is especially strong expression in area CA3, but there is expression in other regions, including the
dentate gyrus (DG).
(O) Tuba8 expression is seen in the inner part of the external granular layer and possibly molecular layer (EGL/ML) and less intensely in
the internal granular layer (IGL). Scale bars represent 150 mm in (A), 500 mm in (B)–(D), 1mm in (E), 100 mm in (F)–(M), and 250 mm in (N)
and (O). The following abbreviations are used: PP, preplate; MZ, marginal zone; and WM, white matter.The American Journal of Human Genetics 85, 737–744, November 13, 2009 741
Figure 5. GFP-TUBA8 Incorporates into
Microtubules within Cells
Individual frames from a time-lapse series
of MDCKII cells stably transfected with
GFP-TUBA8. The fusion protein incorpo-
rates weakly into microtubules (A). Micro-
tubule incorporation was consequently
most evident in cellular structures con-
taining bundled microtubules, such as
the midbody in telophase cells (B, arrow)
or the mitotic spindle (metaphase cell
shown in C). Images in (A) and (B) are
shown in inverted grayscale for improving
image contrast, whereas (C) is shown in
grayscale. Transfected cells were also ﬁxed
and immunostained with antibodies to
a-tubulin (D and E, red) and GFP (E,
green). Nuclei were counterstained with
DAPI (E, blue). (E) shows a merged image.
No obvious abnormalities in microtubule
organization were observed in cells
expressing higher levels of GFP-TUBA8.
Scale bars in (A), (B), and (E) represent
20 mm. The scale bar in (C) represents
10 mm.implies a role for Tuba8 in cortical organization not seen
for either Tuba1a or Tubb2b.
The BFPP gene, Gpr56, which at E10–E16 is principally
expressed in neuronal progenitors within the neurogenic
compartments of the ventricular and subventricular zones,
is absent from the cortical plate and intermediate zone.8
This is quite different from what we report for Tuba8.
BFPP has a distinctive neuroradiological appearance that
classiﬁes it as one of the ‘‘cobblestone’’ defects of neuronal
migration21.
The extensive expression of the tubulins during neuro-
development is likely to reﬂect the essential structural
and transport roles of microtubules in the cellular cytoskel-
eton during development, whereas the more restricted
expression of GPR56 reﬂects its role in the maintenance
of pial basement membrane integrity during the develop-
ment of the cortex.22
The subcellular localization and function of a8-tubulin
are unknown. Given that no antibodies speciﬁc for a8-
tubulin exist, we created MDCKII cell lines stably express-
ing GFP-tagged TUBA8. A full-length human TUBA8 cDNA
cassette was generated by reverse-transcription-PCR and
fused in frame 30 to the EGFP ORF of pEGFP-C1 (Clontech,
Mountain View, CA). MDCKII cells (ECACC, Salisbury, UK)
were cultured in MEM þ 5% fetal bovine serum þ 2 mM
glutamine and transfected with Lipofectamine 2000 (Invi-
trogen Ltd., Renfrew, UK) in accordance with the manufac-
turers’ instructions. Twenty-four hours after transfection,
the medium was supplemented with 1 mg/ml G418 and
refreshed every 2 days thereafter for 2 weeks. Surviving
cells were then trypsinized and replated. Live imaging
and processing for immunuﬂuorescence after ﬁxation in
cold methanol were performed as described.23 Examina-
tion of these cells conﬁrmed that the fusion protein incor-742 The American Journal of Human Genetics 85, 737–744, Novemporated into microtubules (Figure 5A), but at lower
efﬁciency than GFP-tagged a1-tubulin in parallel transfec-
tion experiments (data not shown). The incorporation was
therefore most evident in situations where microtubule
bundles were prominent, such as during mitosis (Figures
5B and 5C). Immunostaining indicated that GFP-TUBA8
expression had no obvious gross impact on the general
organization of the microtubule network in expressing
cells (Figures 5D and 5E). These data therefore conﬁrm
that a8-tubulin participates in microtubule assembly in
mammalian cells.
TUBA8 is an evolutionary outlier within themammalian
a-tubulin family.12 Interestingly, its two most divergent
regions of sequence are known in other family members
to be subject to neurodevelopmentally important post-
translational modiﬁcations.24
The ﬁrst of these modiﬁcations is speciﬁc excision and
religation of a C-terminal tyrosine residue, whose status
modulates the binding of CAP-Gly domain proteins to
microtubule tips,25 thereby inﬂuencing morphological
processes during neuronal differentiation.26 Tubulin tail
modiﬁcations, including detyrosination, inﬂuence the
activity of microtubule-severing factors that are involved
in generating the noncentrosomal microtubule array in
neurons.27 TUBA8 is unlikely to be subject to such modiﬁ-
cations, given that its C-terminal residue is phenylalanine,
as in S. cerevisiae a-tubulin (in which no evidence for an
excision/religation cycle has been found).28
The second modiﬁcation comprises acetylation of lysine
40, a residue conserved in all a-tubulins except TUBA8.
Acetylation of a-tubulin lysine 40 by the Elongator
complex is an important determinant of cortical neuronal
migration in the intermediate zone.29 We have observed
that expression of the nonacetylatable a8-tubulin is lessber 13, 2009
prominent in these migratory neurons, in contrast to their
high level of TUBA1A expression. TUBA8 expression is
more marked in the postmigratory cortical plate neurons.
Therefore, it may be that TUBA1A has a greater role in
migration, whereas TUBA8 has a more prominent role in
local adjustments in cell position after arrival in the
cortical plate. In addition, though, optic nerve hypoplasia
and callosal dysgenesis were consistent features in the
patients described here. This may indicate that the
TUBA8 mutations also impair axon outgrowth and/or
establishment of connectivity. TUBA8 is now the third
tubulin to be implicated in a speciﬁc aspect of cerebral
cortical development. The distinctive phenotypes mani-
fested by the patients harboringmutations in each of these
three genes point to unique cellular roles for their respec-
tive gene products. The high degree of sequence similarity
between members of the a-tubulin family presents a difﬁ-
culty in dissecting out these unique features. For TUBA8,
the important clue, that this isoform lacks the capability
for important regulatory posttranslational modiﬁcations,
offers a useful starting point in this regard.
Finally, the chromosomal localization of TUBA8 is note-
worthy. It is the closest gene proximal to the low-copy
repeat (LCR22-2, LCR-A)30 that mediates recurrent dele-
tion of the DiGeorge/VCFS microdeletion region. Notably,
a small proportion of children with the 22q11.2 microde-
letion syndrome display PMG; indeed, this is possibly the
single most common cause of PMG.31 TUBA8 was not
observed to be deleted in a large DiGeorge/VCFS microde-
letion series.32 It will therefore now be logical to assess the
possibility that a positional effect on TUBA8 expression
underlies the association of DiGeorge/VCFS and PMG.
All annotations and physical positions are recorded as in
NCBI Genome Build 36.3.
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